Abstract
Objective:
The goal of the study was to determine risk factors for maternal cardiac failure in pregnancy complicated with dilated cardiomyopathy (DCM).
Study Design:
The subjects were 29 patients diagnosed with DCM before conception or during the first 7 months of pregnancy. DCM was defined as left ventricle end-diastolic dimension (LVDd)⩾48 mm and/or fractional shortening (%FS)⩽30% on echocardiography. Patients were followed until at least 1 year after delivery and were categorized into a poor prognosis group (n=6; death or end stage heart failure of New York Heart Association (NYHA) class III and IV) and a good prognosis group (n=23; all other cases).
Result:
DCM was initially diagnosed during pregnancy in 6/6 and 8/23 patients in the poor and good prognosis groups, respectively (P<0.005). The %FS of the first test during pregnancy was 17.5±6.2 and 27.4±9.3% in the respective groups (P<0.005). In eight abortion cases with %FS 15.2±3.1%, %FS, cardiac function and NYHA class were maintained until 20 months after abortion. There was no relationship between LVDd and maternal outcome.
Conclusion:
Onset during pregnancy and decreased %FS are risk factors for a poor maternal outcome in patients with DCM. Abortion prevents further deterioration of cardiac function in patients with a very low %FS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dec GW, Fuster V . Idiopathic dilated cardiomyopathy. N Engl J Med 1994; 331: 1564–1575.
Felker GM, Jaeger CJ, Klodas E, Klodas E, Thiemann DR, Hare JM et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J 2000; 140: 785–791.
Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005; 111: 2050–2055.
Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR et al. Natural course of peripartum cardiomyopathy. Circulation 1971; 44: 1053–1061.
Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD et al. Peripartum cardiomyopathy: National Heart, Lung and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000; 283: 1183–1188.
Morales A, Painter T, Li R, Siegried JD, Li D, Norton N et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010; 121: 2176–2182.
Hansan JA, Qureshi A, Ramejo BB, Kamran A . Peripartum cardiomyopathy characteristics and outcome in a tertiary care hospital. J Pak Med Assoc 2010; 60: 377–380.
Kuklina EV, Callaghan WM . Cardiomyopathy and other myocardial disorders among hospitalizations for pregnancy in the United States: 2004-2006. Obstet Gynecol 2010; 115: 93–100.
Goland S, Modi K, Bitar F, Janmohamed M, Mirocha JM, Czer LS et al. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail 2009; 15: 645–650.
Elkayam U, Goland S . Bromocriptine for the treatment of peripartum cardiomyopathy. Circulation 2010; 121: 1465–1473.
Grewal J, Siu SC, Ross HJ, Mason J, Balint OH, Sermer M et al. Pregnancy outcomes in women with dilated cardiomyopathy. J Am Coll Cardiol 2009; 55: 45–52.
Bernstein PS, Magriples U . Cardiomyopathy in pregnancy: a retrospective study. Am J Perinat 2001; 18: 163–168.
Hibbard JU, Lindheimer M, Lang RM . A modified definition for peripartum cardiomyopathy and prognosis based on echography. Obstet Gynecol 1999; 6: 17–36.
Chapa JB, Heiberger HB, Weinert L, Decara J, Lang RM, Hibbard JU . Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 2005; 105: 1303–1308.
Gifford RW, August PA, Cunningham G . Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1.
Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR et al. Summary and recommendation of the fifth international workshop-conference on gestational diabetes mellitus. Diabetes Care 2007; 30: 3154.
Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077–1084.
Teuteberg JJ, Lewis EF, Nohria A, Tsang SW, Fang JC, Givertz MM et al. Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium. J Cardiac Fail 2006; 12: 47–53.
Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM . Peripartum cardiomyopathy: a comprehensive review. Int J Cardiol 2007; 118: 295–303.
Fett JD . Understanding peripartum cardiomyopathy, 2008. Int J Cardiol 2008; 130: 1–2.
Ntusi NB, Mayosi BM . Aetiology and risk factors of peripartum cardiomyopathy: a systemic review. Int J Cardiol 2009; 131: 178–179.
Elkayam U, Tummala PP, Rao K, Akhter MW, Karaalp IS, Wani OR et al. Maternal and fetal outcomes of the subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001; 344: 1567–1571.
Witlin AG, Mabie WC, Sibai BM . Peripartum cardiomyopathy: a longitudinal echocardiographic study. Am J Obstet Gynecol 1997; 177: 1129–1132.
Therrien J, Dore A, Gersony W, Iserin L, Liberthson R, Meijboom F et al. CCS Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease. Part I. Can J Cardiol 2001; 17: 940–959.
Therrien J, Gatzoulis M, Graham T, Bink Boelkens M, Connelly M, Niwa K et al. Canadian Cardiovascular Society Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease–Part II. Can J Cardiol 2001; 17: 1029–1050.
Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003; 24: 761–781.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Katsuragi, S., Omoto, A., Kamiya, C. et al. Risk factors for maternal outcome in pregnancy complicated with dilated cardiomyopathy. J Perinatol 32, 170–175 (2012). https://doi.org/10.1038/jp.2011.81
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2011.81
Keywords
This article is cited by
-
Obesity, not a high fat, high sucrose diet alone, induced glucose intolerance and cardiac dysfunction during pregnancy and postpartum
Scientific Reports (2021)
-
Maternal mortality: changing etiologies will require different approaches
Journal of Perinatology (2012)